UPDATE : Thursday, March 22, 2018
Gaucher disease drug effective for retention, early treatment, Sanofi says
Sanofi Genzyme emphasized the convenience of Cerdelga (Ingredient: eligusta...
by Nam Doo-hyun  |  2018-01-15 10:27
AstraZeneca gets expanded FDA approval for cancer drug
The U.S. Food and Drug Administration said Friday it approved AstraZeneca’s...
by Marian Chu  |  2018-01-15 10:20
Daewoong gets approval to start Nabota BTX clinical trials in China
Daewoong Pharmaceutical is making inroads into the Chinese market with its ...
by Marian Chu  |  2018-01-11 16:24
Drugmakers work on ‘me-too’ drugs of Pradaxa
Hanmi Pharmaceutical, Ahngook Pharmaceutical, Dasan Medichem, and Huons are...
by Lee Hye-seon  |  2018-01-11 16:12
Hanmi slates US-based phase 1 trial for LAPSTriple Agonist: CEO
Hanmi Pharmaceutical is ramping up efforts to enter the global market with ...
by Marian Chu  |  2018-01-11 15:59
Korean drugmakers promote pipelines at JP Morgan event
Korean pharmaceutical and biotech firms publicized their competitiveness, u...
by So Jae-hyeon  |  2018-01-11 15:42
Drugmakers speed up ownership successions
Since the beginning of the New Year, pharmaceutical companies are accelerat...
by So Jae-hyeon  |  2018-01-11 12:01
AstraZeneca gets go-ahead for biologic asthma drug in Europe
AstraZeneca and its global research and development subsidiary MedImmune sa...
by Marian Chu  |  2018-01-11 10:48
Eli Lilly withdraws testosterone replacement therapy from Korea
Eli Lilly and Company has taken its topical testosterone replacement therap...
by Marian Chu  |  2018-01-10 17:11
Drugmakers play it safe under ‘K-Sunshine Act’
Drugmakers are limiting salespersons’ use of corporate credit cards amid co...
by So Jae-hyeon  |  2018-01-10 14:23
AbbVie’s atopic dermatitis drug designated ‘breakthrough therapy’
AbbVie Korea said Wednesday that upadacitinib, its investigational therapy ...
by Marian Chu  |  2018-01-10 14:13
New antihypertensive combos ready for market entry
GC (formerly Green Cross) Pharma, Dongkwang Pharm, and HanAll Biopharma hav...
by Lee Hye-seon  |  2018-01-09 15:17
First plastic tube oral cholera vaccine makes global debut, IVI says
The world’s first plastic tube presentation of oral cholera vaccine, Euvich...
by Marian Chu  |  2018-01-09 12:26
GC Pharma’s high-content vitamin becomes blockbuster drug
GC Pharma said Monday that B-Max, a high-content vitamin, has become a bloc...
by Lee Han-soo  |  2018-01-09 11:49
Leukemia drug faces longer PMS on demand shortage
Il-yang Pharm’s new leukemia treatment Supect (ingredient: radotinib) will ...
by So Jae-hyeon  |  2018-01-09 11:44
5 Korean pharmaceuticals jump into biobetter developing business
Big name Korean pharmaceuticals are shifting their focus to a new type of t...
by Marian Chu  |  2018-01-08 15:59
SillaJen dismisses allegations against its foreign patents
SillaJen denied recent allegations regarding problems with its foreign pate...
by Lee Han-soo  |  2018-01-08 14:30
Janssen to test RSV drug for Korean infants
Janssen said it planned to test its respiratory syncytial virus (RSV) treat...
by Lee Hye-seon  |  2018-01-08 14:29
Biogen’s spinal muscular atrophy treatment gains approval in Korea
Biogen Korea said Monday that it gained approval for its potential blockbus...
by Marian Chu  |  2018-01-08 14:27
Takeda’s lung cancer drug designated orphan drug in Korea
Takeda Pharmaceuticals Korea said Monday the Ministry of Food and Drug Safe...
by Marian Chu  |  2018-01-08 11:19
Back to Top